These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7728751)

  • 1. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region in urinary trypsin inhibition.
    Kobayashi H; Gotoh J; Kanayama N; Hirashima Y; Terao T; Sugino D
    Cancer Res; 1995 May; 55(9):1847-52. PubMed ID: 7728751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.
    Kobayashi H; Gotoh J; Hirashima Y; Fujie M; Sugino D; Terao T
    J Biol Chem; 1995 Apr; 270(14):8361-6. PubMed ID: 7713945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models.
    Kobayashi H; Shinohara H; Fujie M; Gotoh J; Itoh M; Takeuchi K; Terao T
    Int J Cancer; 1995 Nov; 63(3):455-62. PubMed ID: 7591248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
    Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
    Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.
    Kobayashi H; Shinohara H; Ohi H; Sugimura M; Terao T; Fujie M
    Clin Exp Metastasis; 1994 Mar; 12(2):117-28. PubMed ID: 8306525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis.
    Kobayashi H; Shinohara H; Takeuchi K; Itoh M; Fujie M; Saitoh M; Terao T
    Cancer Res; 1994 Feb; 54(3):844-9. PubMed ID: 8306348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the cellular binding site for the urinary trypsin inhibitor.
    Kobayashi H; Gotoh J; Fujie M; Terao T
    J Biol Chem; 1994 Aug; 269(32):20642-7. PubMed ID: 8051163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-alpha-trypsin inhibitor bound to tumor cells is cleaved into the heavy chains and the light chain on the cell surface.
    Kobayashi H; Gotoh J; Hirashima Y; Terao T
    J Biol Chem; 1996 May; 271(19):11362-7. PubMed ID: 8626690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of the cell-associated binding protein for urinary trypsin inhibitor.
    Kobayashi H; Hirashima Y; Sun GW; Fujie M; Shibata K; Tamotsu S; Miura K; Sugino D; Tanaka Y; Kondo S; Terao T
    Biochim Biophys Acta; 1998 Apr; 1383(2):253-68. PubMed ID: 9602143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells.
    Kobayashi H; Fujie M; Shinohara H; Ohi H; Sugimura M; Terao T
    Int J Cancer; 1994 May; 57(3):378-84. PubMed ID: 8168999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tumor invasion and metastasis by peptidic mimetics of Arg-Gly Asp (RGD) derived from the cell recognition site of fibronectin.
    Fujii H; Nishikawa N; Komazawa H; Orikasa A; Ono M; Itoh I; Murata J; Azuma I; Saiki I
    Oncol Res; 1996; 8(9):333-42. PubMed ID: 8979267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cell membrane-associated urinary trypsin inhibitor in tumor cell invasion and metastasis.
    Kobayashi H; Terao T
    Oncol Rep; 1997; 4(1):65-72. PubMed ID: 21590013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identity of urinary trypsin inhibitor-binding protein to link protein.
    Kobayashi H; Hirashima Y; Sun GW; Fujie M; Nishida T; Takigawa M; Terao T
    J Biol Chem; 2000 Jul; 275(28):21185-91. PubMed ID: 10801881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR-3) with a reconstituted basement membrane (Matrigel).
    Kanemoto T; Martin GR; Hamilton TC; Fridman R
    Invasion Metastasis; 1991; 11(2):84-92. PubMed ID: 1917387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of urinary trypsin inhibitor in human uterine fibroblasts.
    Kobayashi H; Hirashima Y; Sun GW; Fujie M; Shibata S; Tamotsu S; Kato K; Morishita H; Terao T
    Pflugers Arch; 1998 Jun; 436(1):16-25. PubMed ID: 9560442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.
    Johnson G; Swart C; Moore SW
    Biochem J; 2008 May; 411(3):507-14. PubMed ID: 18215127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent.
    Kobayashi H; Shinohara H; Gotoh J; Fujie M; Fujishiro S; Terao T
    Br J Cancer; 1995 Nov; 72(5):1131-7. PubMed ID: 7577458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins.
    Hirose J; Ozawa T; Miura T; Isaji M; Nagao Y; Yamashiro K; Nii A; Kato K; Uemura A
    Biol Pharm Bull; 1998 Jul; 21(7):651-6. PubMed ID: 9703243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
    Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.